Literature DB >> 29688701

Nanocomposite Porous Microcarriers Based on Strontium-Substituted HA- g-Poly(γ-benzyl-l-glutamate) for Bone Tissue Engineering.

Shifeng Yan1, Pengfei Xia1, Shenghua Xu1, Kunxi Zhang1, Guifei Li1, Lei Cui2, Jingbo Yin1.   

Abstract

Porous microcarriers have aroused increasing attention recently, which can create a protected environment for sufficient cell seeding density, facilitate oxygen and nutrient transfer, and well support the cell attachment and growth. In this study, porous microcarriers fabricated from the strontium-substituted hydroxyapatite- graft-poly(γ-benzyl-l-glutamate) (Sr10-HA- g-PBLG) hybrid nanocomposite were developed. The surface grating of PBLG, the micromorphology and element distribution, mechanical strength, in vitro degradation, and Sr2+ ion release of the obtained Sr10-HA- g-PBLG porous microcarriers were investigated, respectively. The grafting ratio and the molecular weight of the grafted PBLG of Sr10-HA- g-PBLG could be effectively controlled by varying the initial ratio of BLG-NCA to Sr10-HA-NH2. The microcarriers exhibited a highly porous and interconnected microstructure with the porosity of about 90% and overall density of 1.03-1.06 g/cm3. Also, the degradation rate of Sr10-HA-PBLG microcarriers could be effectively controlled and long-term Sr2+ release was obtained. The Sr10-HA-PBLG microcarriers allowed cells adhesion, infiltration, and proliferation and promoted the osteogenic differentiation of rabbit adipose-derived stem cells (ADSCs). Successful healing of femoral bone defect was proved by injection of the ADSCs-seeded Sr10-HA-PBLG microcarriers in a rabbit model.

Entities:  

Keywords:  femur bone defect; poly(γ-benzyl-l-glutamate); porous microcarriers; strontium-substituted hydroxyapatites

Mesh:

Substances:

Year:  2018        PMID: 29688701     DOI: 10.1021/acsami.8b02448

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  8 in total

Review 1.  Strontium Functionalized in Biomaterials for Bone Tissue Engineering: A Prominent Role in Osteoimmunomodulation.

Authors:  Jiaqian You; Yidi Zhang; Yanmin Zhou
Journal:  Front Bioeng Biotechnol       Date:  2022-07-06

Review 2.  Injectable hydrogels for bone and cartilage tissue engineering: a review.

Authors:  Nafiseh Olov; Shadab Bagheri-Khoulenjani; Hamid Mirzadeh
Journal:  Prog Biomater       Date:  2022-04-14

3.  The effect of enhanced bone marrow in conjunction with 3D-printed PLA-HA in the repair of critical-sized bone defects in a rabbit model.

Authors:  Zhiqing Liu; Wenxiang Chu; Linyuan Zhang; Yueting Wang; Zanjing Zhai; Fengxiang Liu
Journal:  Ann Transl Med       Date:  2021-07

Review 4.  Emerging Fabrication Strategies of Hydrogels and Its Applications.

Authors:  Fayaz Ali; Imran Khan; Jianmin Chen; Kalsoom Akhtar; Esraa M Bakhsh; Sher Bahadar Khan
Journal:  Gels       Date:  2022-03-24

5.  Inverse opal substrate-loaded mesenchymal stem cells contribute to decreased myocardial remodeling after transplantation into acute myocardial infarction mice.

Authors:  Wenbin Lu; JingJing Ji; Genshan Ma; Qiming Dai; Lijuan Chen; Pengfei Zuo; Yuanjin Zhao
Journal:  Int J Nanomedicine       Date:  2018-11-02

Review 6.  Biopolymer-Based Microcarriers for Three-Dimensional Cell Culture and Engineered Tissue Formation.

Authors:  Lixia Huang; Ahmed M E Abdalla; Lin Xiao; Guang Yang
Journal:  Int J Mol Sci       Date:  2020-03-10       Impact factor: 5.923

7.  Porous polyetheretherketone microcarriers fabricated via hydroxylation together with cell-derived mineralized extracellular matrix coatings promote cell expansion and bone regeneration.

Authors:  Shuo Sun; Zixue Jiao; Yu Wang; Zhenxu Wu; Haowei Wang; Qingming Ji; Yi Liu; Zongliang Wang; Peibiao Zhang
Journal:  Regen Biomater       Date:  2021-03-19

Review 8.  Strontium Functionalization of Biomaterials for Bone Tissue Engineering Purposes: A Biological Point of View.

Authors:  Giorgia Borciani; Gabriela Ciapetti; Chiara Vitale-Brovarone; Nicola Baldini
Journal:  Materials (Basel)       Date:  2022-02-25       Impact factor: 3.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.